Get the latest tech news
IXI raises $36.5M from Amazon and others to bring autofocus to prescription glasses
Blink and you’ll miss it: a startup out of Finland is taking a new look at the market for prescription eyewear. Tapping into innovations in eye-tracking
Plural, the London-based VC, is leading the latest tranche of Series A funding, with participation also from Tesi, byFounders, Heartcore, Eurazeo, FOV Ventures, Tiny Supercomputer and IXI’s existing investors. But even with big companies like Meta, Apple, Sony and Microsoft pursuing hardware in the VR space, it’s been a struggle to find a booming market for the technology, with sales growing but still in the single-digit billion category, small for consumer electronics. IXI has a number of patents filed and applied for around their invisibly-smart eyewear, and Eiden and his COO Jussi Havu, in an interview, declined to talk about too many specifics of the glasses, but in a nutshell, it uses a very small device built into the frame to track your eyes and correspond with liquid crystal lenses that then automatically adjust for the wearer to be able to see items in focus.
Or read this on TechCrunch
